Skip to main
SKIN

SKIN Earnings Dates & Reports

SKIN Most Recent Earnings

Report Date
Period EndingQ1 2026
Est. EPS-$0.08
Actual EPS-$0.05
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

SKIN Earnings per Share (EPS) History

Signup for full access
Browse free

SKIN Latest Earnings

The value each SKIN share was expected to gain vs. the value each share gained.

SKIN reported its most recent earnings on for Q1 2026, posting earnings per share (EPS) of -$0.05. This exceeded analysts' expectations of -$0.08 by 37.50%, marking a Beat.

For comparison, The Beauty Health Company reported EPS of -$0.08 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.03.

SKIN Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2026
-$0.03
Q1 2026
-$0.08-$0.05-37.50%
Q4 2025
-$0.06-$0.060.00%
Q3 2025
-$0.06-$0.09+50.00%
Q2 2025
-$0.04$0.03-175.00%
View all

SKIN Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the The Beauty Health Company’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

SKIN Earnings FAQs

SKIN last reported earnings on May 7, 2026 for Q1 2026, posting an EPS of -$0.05, which Beat the estimate of -$0.08 by 37.50%.

For Q1 2026, SKIN reported an EPS of -$0.05, exceeding analysts' estimate of -$0.08 by 37.50%.

For Q1 2026, SKIN Beat expectations with an actual EPS of -$0.05 vs. an estimated EPS of -$0.08.

Following the last earnings report on May 7, 2026, SKIN's stock price moved — from — to —.

The next SKIN earnings call is scheduled for Aug. 6, 2026, where executives will discuss financial results and outlook.

The Beauty Health Company (SKIN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.